Kliničke studije za Gliom u državi Illinois
13 studija za Gliom traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
Službeni tekst studije (engleski)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- University of Chicago Comprehensive Cancer Center, Chicago
- OSF Children's Hospital of Illinois, Peoria
U tijeku regrutacijaFaza 1/2
12 Months – 21 Years · Oba spola · Ažurirano 1. lis 2026. · NCT05099003Targeted Pediatric High-Grade Glioma Therapy
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaOpažajna studija
12 Months – 39 Years · Oba spola · Ažurirano 8. ruj 2026. · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 12 do 39 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Chicago, Chicago
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 3 do 39 godina · Oba spola · Ažurirano 24. kol 2026. · NCT05096481Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 1
Od 1 do 25 godina · Oba spola · Ažurirano 18. kol 2026. · NCT04485559Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 do 130 godina · Oba spola · Ažurirano 12. kol 2026. · NCT05417594A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Northwestern Medicine, Chicago
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. srp 2026. · NCT07464925MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 1/2
Od 1 do 26 godina · Oba spola · Ažurirano 10. srp 2026. · NCT06712875Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaRana faza 1Zdravi dobrovoljci dobrodošli
Od 1 do 21 godina · Oba spola · Ažurirano 29. lip 2026. · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 2
12 Months – 39 Years · Oba spola · Ažurirano 29. svi 2026. · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Northwestern Memorial Hospital, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 13. tra 2026. · NCT06810544rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 1
12 Months – 18 Years · Oba spola · Ažurirano 17. ožu 2026. · NCT04943848Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.